A Phase I Study of APX005M and Cabiralizumab with or without Nivolumab in Patients with Melanoma, Kidney Cancer, or Non–Small Cell Lung Cancer Resistant to Anti-PD-1/PD-L1
Article in Clinical Cancer Research (June 2021)
The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.
Article in Clinical Cancer Research (June 2021)
Article in SLAS DISCOVERY (May 2020)